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Population studiesAbstract Little is known about the prevalence of HBV genotypes/sub-genotypes in Jeddah pro-
vince, although the hepatitis B virus (HBV) was identified as the most predominant type of hepatitis
in Saudi Arabia. To characterize HBV genotypes/sub-genotypes, serum samples from 15 patients
with chronic HBV were collected and subjected to HBsAg gene amplification and sequence analysis.
Phylogenetic analysis of the HBsAg gene sequences revealed that 11 (48%) isolates belonged to
HBV/D while 4 (18%) were associated with HBV/C. Notably, a HBV/D sub-genotype phylogenetic
tree identified that eight current isolates (72%) belonged to HBV/D1, whereas three isolates (28%)
appeared to be more closely related to HBV/D5, although they formed a novel cluster supported by
a branch with 99% bootstrap value. Isolates belonging to D1 were grouped in one branch and
seemed to be more closely related to various strains isolated from different countries. For further
determination of whether the three current isolates belonged to HBV/D5 or represented a novel
sub-genotype, HBV/DA, whole HBV genome sequences would be required. In the present study,
we verified that HBV/D1 is the most prevalent HBV sub-genotype in Jeddah, and identified novel
variant mutations suggesting that an additional sub-genotype designated HBV/DA should be pro-
posed. Overall, the results of the present HBsAg sequence analyses provide us with insights regard-
ing the nucleotide differences between the present HBsAg/D isolates identified in the populace ofse gene;
s; PCR,
Jeddah,
ia. Saudi
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Journal of Biological Sciences (2016), http://Jeddah, Saudi Arabia and those previously isolated worldwide. Additional studies with large num-
bers of subjects in other areas might lead to the discovery of the specific HBV strain genotypes or
even additional new sub-genotypes that are circulating in Saudi Arabia.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Many nations have a heavy financial load from the high per-
centage of both individuals with chronic hepatitis B virus
(HBV) infection and the approximately 400 million HBV car-
riers worldwide. HBV infection leads to the development of
severe liver diseases including cirrhosis and hepatocellular car-
cinoma (HCC) (Norder et al., 1992, 1994). Human HBV is the
prototype member of the family Hepadnaviridae that contains
a circular, partially double-stranded DNA genome of about
3200 bp. HBV DNA contains four overlapping open reading
frames encoding the pre S1/pre S2/S, pre C/C, pol, and X viral
proteins (Fig. 1) (Magnius and Norder, 1995).
Compared to most DNA viruses, HBV has a high rate of
nucleotide substitution although this is lower than the mutation
rate of RNA viruses (Okamoto et al., 1987). Previously, HBV gen-
omes were classified into four genotypes, but recently have been
categorized into eight genotypes designated as A-H. This catego-
rization was based on inter-genotype divergence of at least 8%
of the complete nucleotide sequence or on more than 4% diver-
gence in the HBsAg gene (Arauz-Ruiz et al., 1997; Okamoto
et al., 1987). These genotypes possess different geographical distri-
butions as illustrated in Fig. 2 (Arauz-Ruiz et al., 1997; Chu et al.,
2003; Miyakawa and Mizokami, 2003). Recently, a complex
recombinant of genotypes A, C, and G has been referred to as rep-
resenting a new genotype (I), which was described and sequenced
in northwestern China, Vietnam, and Brazil (Santos et al., 2010).HBV. The colored arrows
polymerase gene; (ORF C/
X gene and (ORF Pre S1/
lali and Alavian, 2006).
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dx.doi.org/10.1016/j.sjbs.2016.03.003In addition, sub-genotypes have been described in certain HBV
genotypes; these are A1-A6 in genotype A (HBV/A), and B1-
B8, C1-C16, and D1-D8 in HBV/B, C, and D, respectively
(Abdou Chekaraou et al., 2010; Mulyanto et al., 2009).
HBV genotypes show a direct correlation with the severity of
liver disease. HBV/C, HVB/D, and HBV/B are associated with
severe liver cirrhosis (Banerjee et al., 2006; Huy et al., 2006;
Kramvis et al., 2008; Sakamoto et al., 2006) and appear to have
a higher incidence of HCC (Chan and Sung, 2006; Liu et al.,
2007; Liu et al., 2011; Sumi et al., 2003; Yuen et al., 2003,
2009). Additionally, patients with either HBV/C or HBV/D have
a lower response rate to treatment with interferon (IFN)c when
compared with those carrying other HBV genotypes (Zo¨llner
et al., 2001). The HBV genotype might also influence the emer-
gence of lamivudine resistance mutations, which appear to be
more strongly associated with HBV/A than HBV/D (Wen, 2004).
HBV surface antigen (HBsAg) can induce protection
against HBV infection as it is related directly to B-cell epitopes
and is considered as the major target of neutralizing antibodies;
therefore, it is used an HBV vaccine (Kramvis et al., 2005). The
completeHBsAg gene consists of three regions: large S, Pre S2,
and Pre S1, which share their C-terminal 226 amino acid resi-
dues (Carman, 1997; Szmuness et al., 1981). Mutant HBsAg
nucleotides might cause amino acid substitutions (EL Hadad
et al., 2013), which could affect the binding of specific anti-
HB antibodies and the detection by conventional diagnostic
assays (Torresi, 2002). In addition, a relationship has been
observed between low antigenicity of HBV (leading to HBV
reinfection) and the increased incidence of HCC in Egyptian
patients with chronic HBV (Tian et al., 2007). Furthermore,
correlations between mutations in theHBsAg gene, particularly
in the Pre S regions, and the development of HCC have been
verified in patients with chronic HBV (Yang et al., 2010).
The prevalence of HBV infection is generally high in Asian
and African countries (Lee, 1997). Saudi Arabia reported HBV
as the most predominant type (53%) of hepatitis infection fol-
lowed by HCV (30%) and HAV (17%) (Alshabanat et al.,
2013). Furthermore, the Jeddah province of Saudi Arabia hosts
large numbers of HBV infected individuals originating from
countrieswithahigh-HBVburdenbecause Jeddah is amain entry
point as well as being the largest commercial port in the country.
For these reasons and because little is known regarding the
HBsAg genotypes/sub-genotype sequences circulating in Saudi
Arabia, and in particular in the Jeddah region (Al-Faleh et al.,
1992; 1999), the present studywas conducted to provide sequence
data of the most commonHBsAg genotypes/subgenotypes circu-
lating in Jeddah for subsequent phylogenetic analysis.
2. Materials and methods
2.1. Patient samples
Serum samples were collected from 17 Saudi patients with
chronic HBV (5 women and 12 men, mean age 32.7 years)otype D hepatitis B surface antigens isolated from Jeddah, Saudi Arabia. Saudi
Figure 2 Worldwide distribution of HBsAg genotypes (A-I) and some subgenotypes. Dark blue represents regions where the genotypes
are highly endemic (>8%), whereas blue and light blue represent regions with intermediate and low endemicity (2.7% and <2%),
respectively. Saudi Arabia was identified as an HBsAg high endemic region (Hou et al., 2005).
Hepatitis B Surface Antigens from Saudi Arabia 3and were randomly selected as they became available from dif-
ferent hospitals in Jeddah; review of the medical records con-
firmed that all samples were positive for HBsAg with no co
infection with either HIV or HCV. The samples were divided
into aliquots and stored at 70 C until used.
The study protocol was reviewed and approved by the
Deanship of Scientific Research Ethics Committee of King
Abdulaziz University and the King Abdulaziz Hospital Ethics
Committee. Written consent was obtained from all patients
after full explanation of the purpose of the study.
2.2. HBV-DNA extraction, amplification, and HBsAg
genotype/sub-genotype determination
HBV DNA was obtained from 17 patient sera samples using
the Mini Elute viral Extraction Kit (QIAGEN, Inc., Valencia,
CA, USA) according to the manufacturer’s instructions. The
resultant HBV-DNA samples were stored at 70 C until use
(McElhinney et al., 2011). The presence of HBV DNA was
determined by nested PCR using a Hot start Taq plus PCRTable 1 Primers for full length HBsAg amplification and their nuc
Primer code Primer sequence
SBFO10 50 GGGTCACCATATTCTTGG 30
SBRO20 50 CCCACCTTAGAGTCCAAGG 30
SBFI30 50 GAACAAGAGCTACCGCATGGG 30
SBRI40 50 CAAGAGACAAAAGAAAATTGG 30
Nucleotide positions are based on the HBV reference sequence (containe
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Journal of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.03.003Master Mix Kit (QIAGEN) using the primers reported in
Table 1. The first round PCR amplification reaction was per-
formed according to the manufacturer’s instructions using
10 ll HBV-DNA and 50 pmol each of primers SBFO10 and
SBRO20. The cycling conditions were performed with an ini-
tial 5 min of preheating at 95 C, followed by 35 cycles of
denaturing for 30 s at 95 C, annealing for 30 s at 52 C,
and an elongation step for 1 min at 72 C, with a final exten-
sion period of 10 min at 72 C. Nested PCR using the
SBFI30 and SBRI40 primers was performed on 10 ll of the
samples negative for PCR products in the first round ampli-
fication. The second round of amplification was performed
with an initial 5 min preheating step at 95 C, followed by
35 cycles of denaturing for 30 s at 95 C, annealing for 30 s
at 55 C, and elongation for 1 min at 72 C, with a final
extension period of 10 min at 72 C. All PCR contamination
precautions were observed and negative controls using sera
from healthy individuals who were not positive for any
HBV markers were included (EL Hadad et al., 2013;
Mulyanto et al., 2011).leotide position.
Primer length Nucleotide position
19 2859–2878
19 873–892
21 2877–2898
21 810–789
d in 3221 bp) that was retrieved from DDBJ/EMBL/GenBank.
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4 S. EL Hadad et al.2.3. Interpretation of HBsAg nucleotide sequences and
phylogenetic analysis
Purified PCR products were sequenced in both directions using
a Big Dye Terminator v3.1 Cycle Sequencing kit (Applied
Biosystems (ABI), Foster City, CA, USA). The ABI Prism
310 genetic analyzer was used for electrophoresis and data col-
lection according to the manufacturer’s protocol. All isolate
sequences were assembled using SeqMan II software (DNAS-
tar Inc., Madison, WI, USA) and multiple alignments with the
reference sequences of HBsAg genotypes and sub-genotypes
(A-I) were confirmed using CLUSTAL W and MEGA 5.2.2
software. Phylogenetic trees were constructed using the
Tamura-Nei model of evolutionary distance, and the topology
was evaluated by bootstrap analysis (1000 replicates) using the
neighbor joining method (Saitou and Nei, 1987; Tamura and
Nei, 1993).
2.4. Amino acid composition analysis
The protein coding regions of the HBsAg (pre S1, Pre S2, and
large S) gene were translated into amino acid sequences using
the standard and universal genetic codes, respectively, and
were compared to the peptide sequences of the surface antigens
of other HBsAg strains that had been retrieved from the DNA
Data Bank of Japan (DDBJ), European Molecular Biology
Laboratory (EMBL), and GenBank databases (Tallo et al.,
2008).
2.5. Nucleotide sequence submission
The base sequence data reported in this study has been submit-
ted to DDBJ/EMBL/GenBank and assigned accession num-
bers KP191641–KP191650 for the 1.2 Kb partial sequences.
3. Results
3.1. Amplification of the HBsAg gene using nested PCR
Nested PCR confirmed the presence of HBV-DNA in 15
(88.3%) out of 17 HBsAg positive samples whereas in the
remaining 2 (11.7%), the absence of HBV DNA was verified
even after the second round of PCR amplification. All positiveFigure 3 PCR amplification of the HBsAg gene using nested
PCR. ‘‘L” represents the 100 bp DNA ladder ranging from 100 to
1200 bp. Lanes 1, 2, and 5 contain DNA fragments of the HBsAg
gene, whereas lanes 3 and 4 show negative results.
Please cite this article in press as: EL Hadad, S. et al., Sequence analysis of sub-gen
Journal of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.03.003PCR products were at the expected size of approximately
1.2 Kb that included almost the entire Pre S1/Pre S2 and S
genomic region (Fig. 3).
3.2. Identification of HBV genotypes and sub-genotypes based
on the complete nucleotide sequence of the HBsAg gene
Phylogenetic analysis of the 1.2 Kb genomic regions from each
sample, corresponding to the complete HBsAg gene and con-
taining approximately the entire Pre S1/Pre S2/S genomic
locus was performed in order to analyze the nucleotide hetero-
geneity of the present isolates with respect to the reference
HBV genotypes (A-I). The completed tree demonstrated nine
distinct clusters comparable to the known HBV genotypes
(A-I); 11 (73%; S028, S118S, S18014, S318S, S140014,
S20014, S140914, S02E12, S2312E, S07E, and S10612E) out
of the 15 new isolates seemed to be more closely related to
HBV/D by nucleotide distance identity, means ±0.034,
whereas 4 (27%) isolates (S4S214, S5S014, S34014, and
S04S) were identified as HBV/C with a nucleotide distance
means ±0.036 that verified this relationship (Fig. 4).
Whole HBsAg reference sequences of 117 HBV/D sub-
genotype strains including the present 11 isolates were used
to generate another phylogenetic tree. The reference sequences
were retrieved from the DDBJ/EMBL/GenBank databases
along with their accession number and country of origin for
identification. All 117 isolates were grouped into clusters that
represented the nine sub genotypes of HBV/D (D1–D8 and
D10). An exclusive subset of eight HBV/D isolates (S18014,
S140014, S20014, 140914, S02E12, S2312E, S07E, and
S10612E) (72%) were observed to be closest to reported
HBV/D1 strains with identities of 97.5–99%, indicating that
these eight HBV/D isolates belonged to sub-genotype D1.
The three remaining isolates (S028, S118S, and S318S) formed
a particular cluster that belonged to subtype DA, despite seg-
regating into a larger cluster related D5 with identities of 94–
96% (Fig. 5).
3.3. Determination of the amino acids specific for HBV/D1
In the present study, all eleven HBV/D isolates exhibited a
common 11 amino acid deletion in the pre S1 region consistent
with the categorization into genotype D. The amino acid
sequence of S18014, S140014, S20014, S140914, S02E12,
S2312E, S07E, and S10612E isolates were compared against
those of HBV/D1 reference sequences retrieved from the
DDBJ/EMBL/GenBank databases representing strains from
different countries such as Egypt, Turkey, Germany, Uzbek-
istan, India, USA, Iran, and China. As indicated in Table 2,
the lack of any amino acid insertion or deletion was confirmed
in all eight HBV/D1 isolates, despite the identification of sub-
stitutions established across the entire Pre S1/Pre S2/S region,
and particularly within the Pre S1 region. Therein, one novel
amino acid substitution was demonstrated in S01612E, S07S,
and S140014 isolates. Two amino acid substitutions were
found to be specific to S02E12 and S07S isolates. Four and five
amino acid substitutions were characterized in S2312E and
S140914 isolates, respectively, while S18014 and S20014
showed six amino acid substitutions. In the Pre S2 region,
one amino acid residue substitution was verified in bothotype D hepatitis B surface antigens isolated from Jeddah, Saudi Arabia. Saudi
1Figure 4 Phylogenetic tree constructed using the neighbor-joining method, based on nine 1.3-kb, full length HBsAg reference sequences
retrieved from the DDBJ/EMBL/GenBank Database representing all HBV genotypes (A-I). All the reference isolates are indicated with
their accession nos. In addition, the 15 Saudi isolates whose nucleotide sequences were determined in the present study (indicated with a
blue closed triangle) are shown; 11 isolates clustered with HBV/D and are represented by the red branches, while 4 isolates were grouped
with HBV/C and are represented by the green branches. Bootstrap values indicate the major nodes as a percentage of the data obtained
from 1000 replications.
Hepatitis B Surface Antigens from Saudi Arabia 5S07S and S140914, and the S20014 isolate showed two amino
acid residue changes in the S region.
3.4. Amino acid changes of HBV/DA isolates in comparison with
other isolates of HBV/D5
Comparison of the amino acid sequences among the complete
HBsAg genes of two references isolates (DQ315779 India and
AB033558 Indonesia) belonging to D5 with the present HBV/Please cite this article in press as: EL Hadad, S. et al., Sequence analysis of sub-geno
Journal of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.03.003DA isolates verified 10 DA-specific amino acid substitutions
in all HBV/DA strains. In the Pre S1 region, these were
Arg28Ala, Pro81Ala, and Gln89Lys; in the Pre S2 region,
Pro162Leu; and in the S region, Phe171Leu, Met288Thr,
Thr290Pro, Gly348Glu, Leu349Val, and Met361Arg were
found. In addition, two unique amino acid residues; Pro149-
His in the Pre/S2 gene and Pro377Leu in the S gene, were
observed in the S318S and S118S strains, respectively
(Table 3).type D hepatitis B surface antigens isolated from Jeddah, Saudi Arabia. Saudi
Figure 5 Phylogenetic tree constructed by the neighbor-joining method, based on the entire nucleotide sequences of the 106 reported
HBsAg genes of sub genotypes D1-D10. The gene sequences are represented by different colored branches as indicated by the accession
no., followed by the country of isolation. The 11 Saudi HBV/D isolates whose entire pre/S1, pre/S2, and S gene sequences were determined
in the present study are indicated with black closed triangles. The HBV/C isolate (X01587) was used as an out group and was indicated
with a brown closed circle. Bootstrap values are indicated for the major nodes as a percentage of the data obtained from 1000 replicates.
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Table 2 Conserved amino acid residues in HBV/D1 isolates.
Conserved amino acid residues in the HBsAg region (Pre S1, Pre S2, S) were derived from the different HBV/D reference sequences retrieved from DDBJ/EMBL/GenBank and from the eight
isolates described in the present study (S18014, S140014, S20014, S140914, S02E12, S2312E, S07E, and S10612E). The amino acid sequence was derived from the nucleotide sequence.
n=No. of sub-genotypes isolates.
Subgenotype-specific substitutions are shown in red.
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Table 3 Conserved amino acid residues in HBV/D5 isolates.
Conserved amino acid residues in HBsAg (Pre S1, Pre S2, S) were
derived from 2 references sequences of HBV/D5 indicated by their
DDBJ/EMBL/GenBank Accession numbers and 3 isolates of the
present study (S028, S118S, and S318S). The amino acid sequence
was derived from the nucleotide sequence.
Sub-genotype-specific substitutions are italicized.
Sub-genotype-unique amino acids are shown in red.
8 S. EL Hadad et al.4. Discussion
HBV has drawn attention for the peculiar geographic distribu-
tion of its nine distinctive immunologic genotypes (Kao et al.,
2003; Liu et al., 2002). Saudi Arabia, and especially Jeddah,
receives millions of pilgrims from various countries annually
because of the Hajj and Umrah seasons. However, despite
the import of the infection, molecular epidemiological data
of the specific HBV genotype and sub-genotype strains circu-
lating in Jeddah are limited (Al-Faleh et al., 1992, 1999). Phy-
logenetic analysis of 15 current isolates demonstrated that
HBV/D is the most dominant HBV genotype (73%) among
Saudi patients with chronic HBV, followed by HBV/C
(27%). This result is consistent with many previous observa-
tions that postulated that the HBV genotype D appeared to
be predominant in the Mediterranean basin, including the
Middle Eastern countries (EL Hadad et al., 2013; Norder
et al., 2004; Saudy et al., 2003), whereas HBV/C was dominant
in Southeast Asian countries (Lusida et al., 2008).
Recently, ten sub-genotypes of HBV/D (D1 to D10) have
been reported, each showing distinct geographical clustering
(Tran et al., 2014). In the present work, eight isolates belong-
ing to HBV/D (S18014, S140014, S20014, S140914, S02E12,
S2312E, S07E, and S10612E) segregated with sub-genotype
D1 reference isolates, and the inter distances equaling 0.006
verified this effect. This result is in agreement with recent stud-
ies that reported the prevalence of HBV/D1 in regions of the
Middle East through North Africa (EL Hadad et al., 2013;
Tran et al., 2014). Additionally, a possible new HBV sub-
genotype (DA) was suggested by 3 isolates, S028, S318S, and
S118S, which showed identity similarities of 9496%.
Many conflicting reports have arisen in the past few years
regarding the identification of novel HBV/D-sub-genotypes.
Recently, new HBV/B3 sub-genotypes have been sorted out
using partial sequence of the S gene (Ghosh et al., 2013). InPlease cite this article in press as: EL Hadad, S. et al., Sequence analysis of sub-gen
Journal of Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.03.003addition, HBV/D9 has been classified from isolates showing
recombination between genotypes D and C in the pre core/core
regions, although the pre-S/S open reading frame did not pos-
sess any unique motifs that could distinguish HBV/D9 isolates
from the other eight sub genotypes of D. Furthermore, the fre-
quent practice of sequencing only the pre-S/S region for defin-
ing genotype/sub genotype can lead to their improper
classification within sub-genotype D3 or D2 (Ghosh et al.,
2013; Tran et al., 2014). The former phenomenon was con-
firmed by our present phylogenetic tree, wherein current Pre
S/S sequence analysis of the JN664922 India isolate placed it
as belonging to HBV/D3 instead of as an HBV/D9 subtype,
as characterized by previous analysis. In the present study,
three current isolates (S028, S318S, and S118S) were clustered
with reference strains representing HBV/D5. However, this
observation did not affect the proposed establishment of a
novel HBV/DA sub-genotype, as the sub-genotype HBV/D6
strains clustered within the HBV/D3 branch. In addition, the
phylogenetic analysis provided corroboration of both HBV/
D9 and HBV/D10 (Yousif and Kramvis, 2013). Thus, whole
genome sequence analysis is required to substantiate whether
the present isolates actually belong to HBV/D5 or represent
a novel sub-genotype, despite that HBV classification was ini-
tially built on the premise of inter-genotype divergence of at
least 8% of the complete nucleotide sequence or more than
4% in the HBsAg gene, which stringencies these isolates meet
(Magnius and Norder, 1995).
The demonstrated importance of illustrating the difference
in theHBsAg nucleotide sequences of the present isolates urges
further study on the differences in the sequences of amino
acids. No alterations in amino acid sequence result from ‘‘non-
sense” nucleotide mutations (Rodriguez-Frias et al., 1999;
Thuy le et al., 2005), whereas ‘‘sense” mutations might lead
to alterations in the amino acid sequence either by substitu-
tion, insertion, or deletion (Weinberger et al., 2000). Therefore,
sense mutations might lead to the creation of mutants with the
specific ability to escape antibody detection and neutralization.
These mutations thus might also lead to re-infection because
HBV replicates through an RNA intermediate synthesized by
the reverse transcriptase of viral genomes (Kfoury Baz et al.,
2001; Kohno et al., 1996; Kreutz, 2002; Miyake et al., 1996;
Ohishi et al., 2004).
As shown in Table 2, the present HBV/D1 isolates (S18014,
S140014, S20014, 140914, S02E12, S2312E, S07E, and
S10612E) showed the presence of 1–8 unique amino acid resi-
dues out of the 390 that represent the entire Pre S/S region.
Amino acid sequence alignments were also performed between
the three HBV/DA isolates (S028, S318S, and S118S) and two
reported reference sequences related to HBV/D5 (DQ315779
India and AB033558 Indonesia) to ensure that the proposed
sub-genotype harbored nucleotide and amino acid motifs that
were specific to the novel sub-genotype. The current HBV/DA
isolates harbored 3, 1, and 6 amino acid residues, respectively
in the Pre S1/Pre S2/S locus that were unique to the proposed
sub-genotype. In addition, two unique amino acid residues,
Pro149His in the Pre/S2 gene and Pro377Leu in the S gene,
were observed in the S318S and S118S strains, respectively
(Table 3). The relatively large number of sense mutations iden-
tified in HBV suggests that this virus might be better at avoid-
ing elimination than HAV and HCV; in addition, HBV might
be more stable than the latter, which are RNA viruses. There-
fore, our result might explain one of the reasons why in Saudiotype D hepatitis B surface antigens isolated from Jeddah, Saudi Arabia. Saudi
Hepatitis B Surface Antigens from Saudi Arabia 9Arabia; the incidence of viral hepatitis is decreasing for both
HAV and HCV, but not for HBV, which showed a minimal
increase. Overall, between hepatitis A, B, and C, HBV was
the most predominant type, accounting for 53% of identified
cases, followed by HCV (30%) and HAV (17%) (Alshabanat
et al., 2013).
5. Conclusion
This study highlighted the sequence analysis of HBsAg genes
isolated from Saudi patients with chronic HBV. The sequence
results obtained from these isolates verified that HBV/D and
HBV/C are the most common genotypes in this population.
This result confirmed previously published findings demon-
strating that HBV/D was the dominant type in the Middle East
(EL Hadad et al., 2013; Liu et al., 2002). In addition, the cur-
rent study revealed the presence of multiple sub-genotypes of
HBV within the D genotype, with the dominant distribution
of the seemingly indigenous sub-genotype D1. Therefore, the
availability of complete HBsAg sequences might serve as a ref-
erence for future epidemiological studies of HBV viruses.
Additionally, this study identified a new sub-genotype, tenta-
tively designated DA in Jeddah, KSA, which meets the pro-
posed rules for HBV/D classification (Norder et al., 2004).
For further confirmation whether the three current isolates
belong to HBV/D5 or represent a novel sub-genotype, HBV/
DA, whole HBV genome sequences would be required. Simi-
larly, additional studies with large numbers of cases in previ-
ously examined and unexamined areas will likely lead to the
discovery of the HBV strains and even possibly additional
new sub-genotype strains circulating in Saudi Arabia.
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